Manchester University NHS Foundation Trust issues £400m EPR tender
[Manchester, UK] Manchester University NHS Foundation Trust (MFT) has issued a tender for an Electronic Patient Record (EPR) system worth up to £400m that will see the 'right' IT provider develop a ‘clinically driven, joint-working based partnership’ with the biggest NHS trust in the country.
MFT was formed in October last year following the merger of the Central Manchester University Hospitals and the University Hospital of South Manchester trusts, and it now runs nine hospitals across six different sites.
The Competition and Markets Authority said at the time the merger would create ‘substantial benefits’ for patients, including ‘more joined up patient record and clinical systems’, reduced duplication and increased research funding opportunities.
BJ-HC understands the Central Manchester University Hospitals trust used an EPR developed in-house, Chameleon, while the University Hospital of South Manchester trust decided to deploy the Sunrise EPR from Allscripts back in 2015.
MFT says it has now developed roadmaps to ensure existing products continue to support services during the procurement and implementation phases.
The trust’s board of directors approved at the beginning of the year a proposal to carry out an open procurement for the EPR, first reported by NS Tech.
Although the total value of the contract is estimated to add up to £400m, the trust says this includes any extensions beyond a 15-year term and a requirement to support ‘any future reconfiguration of healthcare in Greater Manchester’.
MFT says it 'expects the initial contracted solution to cost less than this'; the Health Service Journal [paywall] reported back in January that the organisation applied for a £50m loan for the EPR through the Independent Trust Financing Facility.
The new solution is expected to support the trust in reaching Stage 6 of the HIMSS Electronic Medical Record Model (EMRAM) ‘as quickly as possible’ and Stage 7 ‘as soon as possible thereafter’.
The eight-stage model allows healthcare organisations to track their progress in the adoption and use of digital technology, according to HIMSS Analytics.
More than 2,500 hospitals have been assessed on the EMRAM in Europe; in the UK, only three have been validated at Stage 6.
The trust did not respond to any additional questions.
HIMSS is the parent company of BJ-HC.